首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Pharmacological Research

Pharmacological Research杂志,由Academic Press Inc.出版,于1989年创刊,Monthly,出版语言English,ISSN:1043-6618,E-ISSN:1096-1186。

投稿咨询
Pharmacological Research
Pharmacological Research
Pharmacological Research
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
12.2
CiteScore
19.1
期刊收录
SCI、SCIE

Pharmacological Research(中文译名:《药理研究》),ISSN:1043-6618,EISSN:1096-1186,是Academic Press Inc.出版的国际性学术期刊,创刊于1989年,以Monthly形式稳定发行,2026年总发文量约421篇。该刊采用OA开放访问,学科归属为医学 - 药学。该刊是医学、药学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达12.2,2025年期刊CiteScore为19.1,2025年期刊自引率约1.6%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Pharmacological Research长期聚焦医学、药学及相关产业的技术应用前沿,平均审稿周期偏慢,4-8周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDUSA、Italy、Iran、Australia、England、India等为核心发文国家与地区;UNIVERSITY OF MILANMACAU UNIVERSITY OF SCIENCE & TECHNOLOGY、MASHHAD UNIVERSITY MEDICAL SCIENCE、INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)、BEIJING UNIVERSITY OF CHINESE MEDICINE、CHINESE ACADEMY OF SCIENCES、TEHRAN UNIVERSITY OF MEDICAL SCIENCES等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
PHARMACOLOGY & PHARMACY 药学
1区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
PHARMACOLOGY & PHARMACY 药学
1区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
PHARMACOLOGY & PHARMACY 药学
1区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 13 / 356

96.5

学科:PHARMACOLOGY & PHARMACY SCIE Q1 4 / 356

99.02

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 13 / 352

96.4

学科:PHARMACOLOGY & PHARMACY SCIE Q1 6 / 353

98.44


中国学者近期发文

1
Mitochondrial dysfunction as a driver of chronic pain: New insights and therapeutic prospect

Author:Fan, Yi-Lin; Dai, Fang-Yu; Wang, Jia-Yi; Dai, Xin-Yi; Song, Wen-Lu; Wu, Hong; Gao, Shao-Jie; Tao, Mei; Zhang, Long-Qing; Liu, Tian-Zhu; Yang, Shu-Guang; Liu, Dai-Qiang; Zhou, Ya-Qun; Mei, Wei

Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 227, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108170

2
Endothelial Hippo pathway regulates the neutrophil niche and lung fibrosi

Author:Wu, Chuan; Chen, Xiangqi; Zhou, Jingyue; Wang, Han; Huang, Xiaojuan; Tang, Xiaoqiang; Cao, Zhongwei; Ding, Bi-Sen

Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 227, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108169

3
SERCA2 dysfunction drives vascular calcification via coupling with TSPO-MCU at mitochondria-associated endoplasmic reticulum membrane

Author:Pi, Shixian; Liu, Wanling; Zhao, Junyong; Chen, Hui; Luo, Xianbin; Wu, Shaofa; Song, Jiarou; Chen, Xun; Li, Xue; Luo, Wenjian; Wang, Yirui; Liu, Chuan; Ren, Jun; Li, Tian; Liu, He; Tong, Xiaoyong; Qin, Zhexue

Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 227, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108177

4
Beyond the HPA axis: Synaptic circuits of PVNCRH neurons in stress-related psychiatric disorder

Author:Zheng, Jiayuan; Yue, Na; Tian, Zhanzhuang; Yu, Jin; Li, Bing

Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 227, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108179

5
Comparative efficacy and safety of novel Lp(a)-lowering therapies for ASCVD prevention: A network meta-analysi

Author:Wu, An-xin; Wang, Xing-jin; Zhao, Chen; Hu, Jia-qiang; Li, Jin-wei; Xu, Ying; Li, Yi; Liu, Song

Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 227, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108178

6
Mitochondrial dysfunction and immunoinflammatory remodeling in heart failure: Emerging role of conceptualizationthe mtDNA-cGAS/STING axis and therapeutic opportunitie

Author:Zhang, Xi; Xia, Xiangchen; Zhang, Yanmin; Liu, Xiaomin; Wei, Xiaoyu; Chen, Shichuan; Song, Yuchen; Chen, Yicheng; Pang, Jianzhong; Xu, Qiang; Jia, Fuyun

Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 227, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108195

7
Effect of the maxing huoqiao granule on nonsevere community-acquired pneumonia: A multicenter, double-blind, placebo-controlled randomized tria

Author:Ke, Qingming; Zhao, Caiping; Luo, Shengda; Liu, Yuntao; Ye, Ye; Lin, Xingdong; Zeng, Jing; Liu, Xinghua; Liao, Yang; Li, Hongtao; Chen, Shu; Ren, Hong; Liu, Liang; Pan, Hudan

Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 227, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108186

8
Efficacy of Chinese medicine WW-1 in managing gastric atrophy and intestinal metaplasia in patients with chronic atrophic gastritis: A multicenter, randomized, double-blind, placebo-controlled tria

Author:Yang, Yang; Qin, Zongshi; Du, Sijing; Fang, ShuangShuang; Ma, Yanjun; Liu, Zhaolan; Zhou, Weixun; Liu, Xiuli; Tay, Alfred Chin Yen; Tang, Yanping; Wang, Chuijie; Su, Juanpin; Liu, Fengbin; Shu, Jin; Tian, Xudong; Yang, Qian; Liu, Huayi; Liu, Li; Yu, Tao; Li, Zhenhua; Zhang, Zhe; Li, Yijie; Wang, Xiaosu; Xiong, Guangsu; Liu, Jianping; Duan, Dayue Darrel; Zhang, Ping; Wei, Wei

Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 227, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108176

9
SIRT4-mediated debutyrylation of SUCLG1 rescues myocardial energy failure in HFpEF: Ginsenoside Rb3 as a novel SIRT4-interacting regulator?

Author:Yu, Xiaohan; Guo, Yingfei; Liu, Shenfan; Li, Shiqi; Liu, Yuntao; Jin, Lili; Wang, Yuanping; Liu, Zhongqiu; Cheng, Yuanyuan; Wang, Dawei

Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 227, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108196

10
Chemotherapy-induced gastrointestinal dysfunction: Mechanisms and integrative Western-Chinese medicine strategie

Author:Chen, Rui; Liu, Limin; Lin, Ying; Yang, Boyan; Wang, Jiajian

Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 227, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108191


在线咨询

Pharmacological Research

国际简称:PHARMACOL RES参考译名:药理研究

年发文量:421 CiteScore:19.1 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:93.59%

杂志社联系方式:ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, 24-28 OVAL RD, LONDON, ENGLAND, NW1 7DX

Pharmacological Research